IACAPAP Special Interest Group Webinar on International Pediatric Psychopharmacology

Join the launch webinar of the IACAPAP International Pediatric Psychopharmacology Special Interest Group (IPP SIG) — a new global forum for sharing resources, exchanging best practices, and fostering collaboration among child and adolescent psychiatrists and allied mental health professionals. 
 
We’ll explore: 
• How the GRADE approach can help us critically appraise and apply pediatric psychopharmacology evidence. 
• Compare national and regional prescribing practices with best evidence, exploring why differences exist. 
• Brainstorm strategies for bridging gaps between research and real-world practice worldwide at the clinician and advocacy/policy levels. 
• Identify opportunities for collaborative scholarship, networking, and resource sharing. 
 
Be part of a vibrant, bidirectional learning community working toward equitable, evidence-based care for all children and adolescents. 

Date & Time 

Thursday, November 20th, 2025
1:00 PM CET | 7:00 AM EST | 12:00 PM UTC | 11:00 AM AEST

Speaker

Boris Lorberg, MD, MBA
 

Medical Director. Lawrence Community Behavioral Health Center. Beth Israel Lahey Health Behavioral Services.


Associate Professor of Psychiatry. UMass Chan-Lahey. University of Massachusetts Chan Medical School.

 

Dr. Boris Lorberg is an academic child and adolescent psychiatrist, board-certified in both general and child psychiatry. Born and raised in Kyiv, Ukraine, he earned his medical degree from Stony Brook University School of Medicine (USA) in 2004. He completed his General Psychiatry Residency at Yale University (Levine Award for Clinical Excellence, Breadth of Learning, and Dedication to the Care of Severely Ill Psychiatric Patients). He then pursued a Child and Adolescent Psychiatry Fellowship at Harvard University (MGH/McLean Hospital), receiving the Laughlin Award from the American College of Psychiatrists, a prestigious recognition for future leaders in the field. In 2017, he expanded his expertise in healthcare leadership by earning a Physician’s MBA from the Heller School of Social Policy and Management at Brandeis University.

Dr. Lorberg has made significant contributions to psychiatric education, psychopharmacology, and professional development. He has played an integral role in the American Academy of Child and Adolescent Psychiatry (AACAP), leading national forums and workshops on pediatric psychopharmacology, early career mentorship, and leadership training. From 2009 to 2014, he led a workgroup within AACAP’s Pediatric Psychopharmacology Initiative (PPI), where he helped develop clinical resources on FDA indications and evidence quality for psychotropic medications in children. He also co-authored the AACAP-APA Parent Medication Guides for childhood depression, ADHD, and bipolar disorder, which remain freely available to families and clinicians (http://www.parentsmedguide.org/).

Read more

Important note: 

  1. The webinar is open to the public. 
  2. This webinar will be conducted virtually via Zoom. 
  3. Participation is free, but registration is required in advance. Seats are limited, and it's based on first-come, first-served. After registration, a copy of the webinar confirmation email will be sent. By registering for a webinar, consent is given for registration details to be provided to IACAPAP for webinar preparation. 
  4. No certificate of attendance will be provided. 
  5. IACAPAP reserves the right at all times to change, add or remove any terms without prior notice. 
  6. IACAPAP reserves the right to make alterations to the webinar program at any time.